Numerous studies demonstrated that a high TMB and high PD-L1 expression were conducive for immune cells recognition and elimination of tumor cells, which makes patients sensitive to ICI therapy (Reck et al., 2016; Chan et al., 2019; Liu et al., 2019). Here, CD274 is linked to neoplasm.